Search results
Showing 2596 to 2610 of 7685 results
In development [GID-TA11498] Expected publication date: 10 September 2025
Tofersen for treating amyotrophic lateral sclerosis caused by SOD1 gene mutations [ID3767]
In development [GID-HST10062] Expected publication date: TBC
Digital technologies to support smoking cessation in secondary care patients: early value assessment
Awaiting development [GID-HTE10061] Expected publication date: TBC
Artificial intelligence technologies for mammography: early value assessment
Awaiting development [GID-HTE10062] Expected publication date: TBC
Digital platforms to support self-management of asthma : early value assessment
Awaiting development [GID-HTE10063] Expected publication date: TBC
Balloon disimpaction of the baby's head at emergency caesarean during the second stage of labour
In development [GID-IPG10408] Expected publication date: 16 April 2025
Dupilumab for treating severe chronic rhinosinusitis with nasal polyposis (Review of TA648) [ID6480]
In development [GID-TA11630] Expected publication date: 11 September 2025
Vutrisiran for treating transthyretin-related amyloidosis with cardiomyopathy [ID6470]
In development [GID-TA11598] Expected publication date: TBC
Evidence-based recommendations on Kinesia 360 and KinesiaU (Great Lakes NeuroTechnologies), PDMonitor (PD Neurotechnology), Personal KinetiGraph (Global Kinetics) and STAT-ON (Sense4care) for remote monitoring of Parkinson’s disease
Depth of anaesthesia monitors – Bispectral Index (BIS), E-Entropy and Narcotrend-Compact M (DG6)
Evidence-based recommendations on 3 electroencephalography (EEG)-based depth of anaesthesia monitors for assessing a patient’s response to anaesthetic drugs during surgery. The monitors are Bispectral Index (BIS), E-Entrophy and Narcotrend-Compact M
E‑vita open plus for treating complex aneurysms and dissections of the thoracic aorta (MTG16)
Evidence-based recommendations on the E-vita open plus for treating complex aneurysms and dissections of the thoracic aorta.
Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care (MTG65)
Evidence-based recommendations on Sedaconda ACD-S for sedation with volatile anaesthetics in intensive care.
View recommendations for MTG65Show all sections
Evidence-based recommendations on Alpha-Stim AID for managing anxiety disorders.
View recommendations for MTG56Show all sections
Evidence-based recommendations on the ReCell Spray-On Skin system for treating skin loss, scarring and depigmentation after burn injury.
Evidence-based recommendations on the RD-100i OSNA system and Metasin test for detecting sentinel lymph node metastases in people having breast cancer surgery